Synthetic small interfering RNAs (siRNAs) that are 21-23 nucleotides (nt) in length have been shown to effectively silence specific target genes by promoting mRNA degradation in cultured mammalian cells and mice 6, 7 . In cultured cells, there are reports of nonspecific gene target effects that include off-target gene suppression and upregulation of type I interferons (IFNs) a and b [2] [3] [4] [5] 8 . Hypotheses for the IFN response include recognition of the siRNA by Toll-like receptors 3 (TLR3) and 9 (TLR9) and/or induction of protein kinase PKR pathways.
Toll-like receptors play critical roles in the detection of microbial infection in mammals by recognizing conserved microbial structures [9] [10] . Both single-(ssRNA) and double-stranded RNA (dsRNA) are molecular structures associated with viral infection; whereas ssRNA has been shown to interact with TLR7 [11] [12] [13] and TLR8 13 , dsRNA is the ligand for TLR3. Polyinosinic acid:polycytidylic acid (poly(I:C)), an analog of dsRNA, is recognized by TLR3 1, 14 and elicits immune responses in mice 1, 14 (TLR3 does not recognize ssRNA or double-stranded DNA (dsDNA)). Since siRNA duplexes are dsRNA, they have the potential to elicit immune response patterns different from all previously used nucleic acid therapeutics. TLR9 can recognize 2¢-deoxyribo(cytidine-phosphate-guanoside) (CpG) dinucleotides flanked by specific sequences in bacterial DNA and in synthetic oligonucleotides 15 . However, synthetic oligonucleotides with dC or dG substituted for by ribonucleotides have much less immune stimulation in mice 16 . It is possible that siRNA duplexes will not be good ligands for TLR9, but this postulate remains unproven. Thus, if siRNAs are ever to become human therapeutics, it is important to establish in vivo whether siRNA duplexes produce immune responses.
The intracellular signal transduction pathways of TLR3 and TLR9 are known to promote transcription of genes regulated by the NFkB transcriptional activator that include cytokines such as interleukin-12 (IL-12) 1, 17 . We compared the effect of poly(I:C) and siRNA on cultured RAW-264.7 cells, a mouse monocyte/macrophage line that can be induced to secrete cytokines 1 or express an NFkB-dependent reporter gene 14 by stimulation with poly(I:C). We exposed RAW-264.7 cells to various doses of either poly(I:C) or a synthetic siRNA duplex against luciferase (siGL3) for 24 h and measured levels of secreted IL-12(p40) in cell supernatants by enzyme-linked immunosorbent assay (ELISA) (Fig. 1a) . Lipopolysaccharide (LPS), which is known to induce a strong IL-12 response through interaction with Toll-like receptor 4 (TLR4) 18 , was used as a positive control for the detection of IL-12 in the assay. At all three doses examined, poly(I:C) invoked a clear IL-12 response. In contrast, synthetic siRNA failed to induce a measurable IL-12 response at any dose. Pre-treatment of poly(I:C) with RNase ( Supplementary Fig. 1 online) completely abrogated the IL-12 response.
The effect of siRNA on IL-12 secretion was further examined in female BALB/c mice. Administrations of synthetic siRNA duplexes or poly(I:C) were performed as intraperitoneal (IP) injections or via the tail vein using either 'low-pressure' (LPTV, 1% vol/wt) or 'highpressure' (HPTV, 10% vol/wt) methods 19, 20 and blood was collected 2 h after injection. ELISA analyses of plasma IL-12 levels show, for each of three different injection types, a strong induction by poly(I:C) that is absent with either an siRNA against FAS (also known as Tnfrsr6), c-MYC, or luciferase, (siFAS, siCMYC, or siGL3) or RNasetreated poly(I:C), even when the siFAS dose is increased up to threefold (Fig. 1b,c) . Further, injected synthetic siRNAs (siFAS and siCMYC) fail to induce any significant changes in critical blood chemistry or liver enzyme levels except for the cases where the HPTV method of injection is used ( Supplementary Fig. 2 online) .
The siFAS sequence does not contain any CpG motifs whereas the siGL3 and siCMYC sequences contain two and three, respectively. No IL-12 response is observed here as the number of CpG repeats is increased from zero to three.
It is known that TLR3 is located both on the cell-surface and intracellularly in human fibroblasts but remains intracellular in others such as monocyte-derived immature dendritic cells 21 . CpG-containing oligonucleotide/TLR9 interactions require internalization of the nucleic acid within TLR9-bearing cells 22 . Thus, proof of nucleic acid stability and intracellular localization in the mice are necessary. In vitro stability studies show that B50% of siRNA is still intact after exposure to serum for 2 h ( Supplementary Fig. 3 online) and downregulation of genes can occur for several days in cultured cells (see, for example, ref. 23 ; for the RAW-264.7 cells specifically, the data are provided in Supplementary Fig. 4 online). Additionally, we injected BALB/c mice with a luciferase-containing plasmid (encoding the firefly luciferase gene under the control of the liver-specific hAAT promoter with ApoE HCR enhancer) alone or co-injected this plasmid with siRNA that contains the appropriate sequence to perform luciferase downregulation (siGL3) or an unrelated sequence (siCNTL); all injections were HPTV. The in vivo luciferase expression was followed for two weeks after injection by live whole-animal imaging 23, 24 . A representative image containing one mouse from each of the three treatment groups is shown in Figure 2a . The cumulative signal from each mouse was quantified at each time point and the results are plotted in Figure 2b (see also Supplementary Fig. 5 online). Mice co-injected with the luciferase-targeting siRNA display a significant (P o 0.1 or better for all time points) downregulation of luciferase expression that is not observed with the control siRNA. The sequence-specific RNAi demonstrates that intact siRNA duplexes do reach intracellular targets and are functional at the conditions of our studies. HPTV injection of siFAS reduces the level of FAS mRNA in mouse liver (Fig. 2c) . This downregulation was not seen upon LPTV injection of the same siRNA at the same dose, consistent with previous observations that high-pressure is required to achieve downregulation of a target gene by siRNA in mice, even if the siRNA is chemically stabilized 23 .
The HPTV method of administrating siRNA provides for cellular uptake and gene downregulation in the livers of mice 7, 23, 25 . In addition to determining IL-12 concentrations, these experiments allow us to test for interferon responses. The plasma levels of IFN-a in mice exposed to siRNA (siFAS, siGL3 or siCMYC) or poly(I:C) were measured by ELISA (Fig. 3) . As observed with IL-12, each siRNA failed to elicit an IFN-a response whereas poly(I:C) induced a strong response that was eliminated by pre-treatment with RNase. Given the stability and efficacy of multiple siRNAs, the lack of IL-12 and IFN-a expression obtained in mice suggests that the synthetic siRNAs used in this study do not elicit an observable immune response when administered naked by LPTV, HPTV or IP methods in the amounts used here. There is the possibility that the PKR response in BALB/c mice may be compromised relative to other mouse strains 26 . Researchers have shown IL-12 responses to poly (I:C) in vitro with RAW-264.7 cells and in serum after IP injection in C57BL/6 mice like those shown here with the same cell line and BALB/c mice 27 . We reproduced some of our experiments performed with the BALB/c mice in C57BL/6 mice, and the results show that the effects observed are consistent within those two strains ( Supplementary Fig. 6 online) . Researchers have shown from in vitro studies that there is an upregulation of interferon-stimulating genes upon transfection of cells with certain types of siRNAs using lipid vectors 2 . An interferon response from expressed siRNAs has also been measured in cultured cells, again using lipid delivery systems 3 . It has been demonstrated that the method of siRNA preparation can determine whether or not an interferon response is observed in culture and that purely synthetic siRNAs like those used here do not elicit such a response 5 . Many researchers 28, 29 have shown that lipid delivery of synthetic siRNAs can induce immune activation in vitro and in vivo by measuring protein levels in cell supernatants and serum, respectively. Additionally, results of an in vitro study indicate that only certain siRNA sequences and cell types induce the activation of TNF-a and IL-6 29 . With naked plasmid DNA that expresses human factor IX, others have observed that neutralizing antibodies to the human factor IX were not elicited from the use of a HPTV injection in BALB/c mice whereas antibodies were observed from injection in skeletal muscle 30 . These studies suggest that there are at least four issues that need further investigation: (i) the method of siRNA preparation and its sequence, (ii) the effects of cell type (e.g., hepatocytes versus macrophages), (iii) the effects of intracellular trafficking between lipid-(and polycation-) delivered siRNAs and the HPTV method (HPTV methods may not exploit the same pathways of cellular internalization 20 as lipids and polycations) and (iv) the effects of concentration in points (i-iii) since concentration effects have been shown to be important in in vitro studies using lipid delivery systems. What is important from the results presented here is that there is a mechanistic pathway that allows for siRNAs to downregulate both endogenous and exogenous targets in the liver without stimulating an interferon response. Further investigation into the details of this pathway should provide insights into the development of methods to perform this type of delivery in a manner that would be relevant for human therapeutics.
In conclusion, we examined the response of mice to naked siRNAs. Serum IL-12 and IFN-a levels that were observed in mice by injection of poly(I:C) (used as a positive control) were not obtained with siRNA. Pre-digestion of poly(I:C) with RNase abrogated these responses. Co-injection of siRNA and a luciferase-expressing plasmid into mice followed by in vivo whole body imaging confirms the uptake and sequence-specific function of injected synthetic siRNA. HPTV injection of siRNA alone was also shown to downregulate an endogenous target gene (FAS) in mice. In general, synthetic siRNAs are well tolerated in mice.
METHODS
Nucleic acids. Poly(I:C) was purchased from Amersham Biosciences. SiRNA duplexes against luciferase (''siGL3''), Fas (''siFAS''), c-myc (''siCMYC''), and a nontargeting control duplex (''siCNTL'') were purchased from Dharmacon. All came purified and pre-annealed by the manufacturer (''Option C''). Sequences (CpG motifs in bold):
siGL3: 5¢-CUUACGCUGAGUACUUCGAdTdT-3¢ 3¢-dTdTGAAUGCGACUCAUGAAGCU-5¢ siFAS:
5¢-GUGCAAGUGCAAACCAGACdTdT-3¢ 3¢-dTdTCACGUUCACGUUUGGUCUG-5¢ siCMYC:
5¢-UCCCGCGACGAUGCCCCUCdTdT-3¢ 3¢-dTdTAGGGCGCUGCUACGGGGAG-5¢ siCNTL:
5¢-GACGUAAACGGCCACAAGUUC-3¢ 3¢-CGCUGCAUUUGCCGGUGUUCA-5¢ The luciferase-encoding plasmid (containing the firefly luciferase gene under the control of the human a 1 -antitrypsin promoter and the apolipoprotein E locus control region) was a generous gift of A. McCaffrey and M. Kay. Where indicated, nucleic acids were pre-incubated with 50 mg/ml RNase (Roche) at 37 1C for 30 min before use. RAW-264.7 studies. RAW-264.7 cells were purchased from the American Type Culture Collection and cultured in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine serum (heat-inactivated) and antibiotics. We plated 5 Â 10 6 cells per well of a 24-well plate in medium containing 1.2% DMSO. After 24 h, mIFN-g (Sigma) was added for 8 h to stimulate TLR3 expression. LPS (1 mg/well; Sigma), poly(I:C) or siRNA (siGL3) in indicated doses was added directly to appropriate wells for 24 h before harvesting the supernatant. IL-12(p40) levels were measured by ELISA (BD Biosciences) according to the manufacturer's instructions.
Mouse studies. Female BALB/c and C57BL/6 mice (Jackson Laboratories) were treated according to the NIH Guidelines for Animal Care and as approved by the Caltech Institutional Animal Care and Use Committee. All mice were 6-8 weeks of age at the time of injection. siRNA was formulated in D5W (5% wt/vol glucose in water) such that a 10% (vol/wt) injection provided a 2.5 mg/kg dose, unless otherwise indicated. Mouse tails were warmed with a heating pad before injection of a 0.2-ml (for 'low-pressure') or a 2-ml (for 'high-pressure') volume (per 20-g mouse) over B3-5 s. For co-injections of siRNA with plasmid DNA, 0.25 mg/kg DNA was delivered with 2.5 mg/kg of the appropriate siRNA. To determine luciferase levels, 0.2 ml of a 15 mg/ml solution of D-luciferin (Xenogen; in PBS) was injected intraperitoneally 10 min before imaging. To measure plasma cytokine levels, blood was harvested from mice 2 h after injection by cardiac puncture, and plasma was isolated using Microtainer tubes (Becton Dickinson). (In preliminary experiments comparing the IL-12 response at 2 h, 6 h and 24 h, after injection, the maximum response was consistently observed at 2 h; therefore, data from the 2-h time point is used here.) IL-12(p40) and IFN-a levels (PBL Biomedical Laboratories) were measured by ELISA according to the manufacturer's instructions. To measure FAS mRNA levels, total RNA was isolated from B100 mg of liver tissue using the FastRNA Pro Green Kit (Qbiogene) and FastPrep Instrument (Qbiogene) for 40 s at a speed setting of 6.0. 1 mg total RNA was first digested with amplification grade DNase I (Invitrogen) and then reverse transcribed into double-stranded cDNA using oligo-dT and Superscript II (Invitrogen) following the manufacturer's instructions. PCR primers were designed with MacVector 7.0 (Accelrys). The primer sequences are:
FAS (sense): 5¢-GCAAACCAGACTTCTACTGCGATTC-3¢ FAS (antisense): 5¢-CCTTTTCCAGCACTTTCTTTTCCG-3¢ For each PCR reaction, 1/40 (1 ml) of the cDNA reaction was amplified in a 25 ml reaction volume containing 0.5 mM of each primer and QuantiTect SYBR Green master mix (Qiagen). The real-time quantitative PCR was performed and analyzed on SmartCycler (Cepheid). Standard curves were constructed by four serial tenfold dilutions of cDNA starting from 1/20 (2 ml) of the cDNA reaction. Initial PCR conditions were 95 1C for 900 s; followed by 40 cycles of [95 1C for 15 s, 55 1C for 30 s and 72 1C for 30 s]; then a final denaturing stage of gradually increasing temperature from 60 1C to 95 1C. The denaturing stage is used to generate the melting curve of PCR products, which correlate with the size and GC content of the PCR product. A parallel internal control (b-actin) was amplified at an annealing temperature of 60 1C. All PCR products were analyzed on a 1% (wt/vol) agarose gel and a single band corresponding to the desired PCR product was observed in all reactions except negative controls. The reproducibility of the quantitative measurement of each sample was evaluated by at least three PCR measurements. The expression level of target gene was normalized to internal b-actin and the mean and standard deviation of the target/b-actin ratios were calculated for sample-to-sample comparison.
Note: Supplementary information is available on the Nature Biotechnology website.
